By Ben Tyler, Corporate Counsel
It is a great time to be a part of ASEA. I have spent many years in the network marketing industry, working with large and well established companies, and also working for new startups. I have seen a lot of different companies selling a wide variety of products, but I have rarely seen something as new and unique as ASEA.
Safeguard ASEA

I know that many of you realize how powerful our products are. You have been sharing them with your friends and neighbors, and you have seen their impact in your own life. You know that these products are effective, that they are for real, and that they are literally changing people’s lives.

The science and the research behind our products give us an effective tool to use as we introduce them to others. This product literally began with a scientific breakthrough and has been expanded and enhanced by ASEA’s own team. A lot of companies spend years trying to develop the support that we already have.

At times it is tempting to try to go beyond the messages and the information that our marketing and sales teams have developed, but that is dangerous and could potentially attract unwanted regulatory scrutiny. The internet has vastly expanded your reach, allowing you to contact people all around the world. It is important to understand that reach also brings the attention of regulators whose job it is to search for impermissible product claims. What you say on your blog or your web page is no longer limited to your close circle of friends and family.

Some of you know that the FDA recently sent letters to some essential oil companies regarding claims made about their products, particularly about the effect of those products on Ebola. It is a common practice for the FDA to focus on a particular disease claim, especially one that is making headlines like Ebola is now. The interesting thing about the recent letters is that the FDA sent a letter to the company about websites created by their independent distributors as opposed to the corporate website.

In the past, the FDA has primarily focused on the actions of the company itself and has held companies responsible for their printed material and their corporate web pages. These recent letters seem to indicate a shift in the enforcement of the FDA to put more pressure on companies for the actions of each of their independent distributors. ASEA has a good record in this regard, but the actions of just a handful of associates can have potentially negative consequences.

We, as a company, are going to do all we can to help you by reviewing associate web pages for any claims that are prohibited under the law. We also encourage all of you to remind the people on your teams to be careful about what they say on web pages, which are easily searched, and to avoid claims that could show up in a letter from the FDA.

Here are three suggestions that you can use and share with others to guide your marketing of ASEA products:

1) Stick with the language used in official company literature and the company web page
2) Avoid any discussion of a disease or a claim that our products cure or treat a disease.
3) If you have questions concerning a story or a statement you would like to use, contact the Associate Education and Conduct department at ASEA.

As we market the ASEA story—including our groundbreaking products and business opportunity—in ways consistent with federal, regional and local laws and regulations, we ensure everyone’s continued ability to share our life-changing products and to pursue the ASEA business opportunity unhindered. When we choose not to ignore these laws and statues, everyone’s opportunity to use ASEA products or engage in the ASEA business opportunity is potentially compromised.

Let’s all work together to safeguard our ability to market ASEA products and our accompanying business opportunity now and in future.